Kinase inhibitors

National Institute of Diabetes and Digestive and Kidney DiseasesUS$3.8mHealth and Medical Research FundHK$1.2mFundacao de Amparo a Pesquisa do Estado de Sao Paulo

• Novel Selective Type II kinase Inhibitors to treat Diabetes

  National Institute of Diabetes and Digestive and Kidney DiseasesIcahn School of Medicine at Mount SinaiUS$674.4k2018–2023

• Clonal hematopoiesis of undetermined potential as a genetic factor in contribution of cardiovascular changes in patients with chronic leukemia in treatment with tyrosine kinase inhibitors

  Fundacao de Amparo a Pesquisa do Estado de Sao PauloHospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo2021–2024

• Therapeutic effects of brain-penetrable kinase inhibitors to prevent accumulation of pathogenic alpha-synuclein oligomers in Parkinson’s disease

  Health and Medical Research FundThe University of Hong KongHK$1.2m2016